Bleeding and thrombotic events in patients with colorectal cancer treated with bevacizumab and receiving novel oral anticoagulants and antiplatelet medications.

被引：0
|
作者：
Rho, Shinji
Wang, Chris
Dehkordi, Seyed Hamed Hosseini
Sears, Jerod J.
Hu, Zishuo Ian
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
104
引用
收藏
页码：104 / 104
页数：1
相关论文
共 45 条
  • [21] NOVEL ORAL ANTICOAGULANTS (NOACS) ADHERENCE AND BLEEDING EVENTS IN ATRIAL FIBRILLATION PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Abegaz, T. M.
    Tamrat, B.
    Bahagavathula, A.
    Abdulla, A.
    Asim, A.
    VALUE IN HEALTH, 2017, 20 (05) : A272 - A273
  • [22] High-Sensitivity C-Reactive Protein and Bleeding Events in Atrial Fibrillation Patients Treated With Direct Oral Anticoagulants
    Shinohara, Tetsuji
    Takahashi, Naohiko
    CIRCULATION JOURNAL, 2020, 84 (03) : 376 - 377
  • [23] Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study
    N B Leighl
    J Bennouna
    J Yi
    N Moore
    J Hambleton
    H Hurwitz
    British Journal of Cancer, 2011, 104 : 413 - 418
  • [24] Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study
    Leighl, N. B.
    Bennouna, J.
    Yi, J.
    Moore, N.
    Hambleton, J.
    Hurwitz, H.
    BRITISH JOURNAL OF CANCER, 2011, 104 (03) : 413 - 418
  • [25] Bleeding Outcomes of Gastrointestinal Cancer Patients Treated with Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin
    Angelini, Dana E.
    Attia, Doaa
    Wei, Wei
    Wilks, Mailey L.
    Tripp, Barbara
    D'Andrea, Christopher
    McCrae, Keith R.
    Khorana, Alok A.
    BLOOD, 2020, 136
  • [26] Warfarin, not direct oral anticoagulants or antiplatelet therapy, is associated with increased bleeding risk in emergency general surgery patients: Implications in this new era of novel anticoagulants: An EAST multicenter study
    Anandalwar, Seema P.
    O'Meara, Lindsay
    Vesselinov, Roumen
    Zhang, Ashling
    Baum, Jeffrey N.
    Cooper, Amanda
    Decker, Cassandra
    Schroeppel, Thomas
    Cai, Jenny
    Cullinane, Daniel
    Catalano, Richard D.
    Bugaev, Nikolay
    LeClair, Madison
    Feather, Christina
    McBride, Katherine
    Sams, Valerie
    Leung, Pak Shan
    Olafson, Samantha
    Callahan, Devon S.
    Posluszny, Joseph
    Moradian, Simon
    Estroff, Jordan
    Hochman, Beth
    Coleman, Natasha
    Goldenberg-Sandau, Anna
    Nahmias, Jeffry
    Rosenbaum, Kathryn
    Pasley, Jason
    Boll, Lindsay
    Hustad, Leah
    Reynolds, Jessica
    Truitt, Michael
    Ghneim, Mira
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2024, 97 (02): : 225 - 232
  • [27] Serious bleeding events are uncommon in patients with metastatic colorectal cancer receiving bevacizumab as part of a first-line regimen. results from the brite observational cohort study
    Kozloff, M.
    Sugrue, M.
    Chiruvolu, P.
    Feng, S.
    Purdie, D.
    Grothey, A.
    Sargent, D.
    Berlin, J.
    Kabbinavar, F.
    Dong, W.
    Flynn, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 25 - 25
  • [28] BEVACIZUMAB-BASED CHEMOTHERAPY AND THROMBOTIC EVENTS RISK IN COLORECTAL CANCER PATIENTS: A META-ANALYSIS STUDY OF RANDOMIZED CONTROLLED TRIALS
    Alahmari, A. K.
    Guo, J. J.
    VALUE IN HEALTH, 2014, 17 (03) : A72 - A72
  • [29] Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study
    Lau, Wallis C. Y.
    Douglas, Ian J.
    Wong, Ian C. K.
    Smeeth, Liam
    Lip, Gregory Y. H.
    Leung, Wai K.
    Siu, Chung-Wah
    Cheung, Bernard M. Y.
    Mok, Michael T. C.
    Chan, Esther W.
    HEART RHYTHM, 2020, 17 (01) : 33 - 40
  • [30] The incidence of major bleeding in adult patients with urogenital and gynecological cancer being treated with direct oral anticoagulants (DOACs): a systematic review
    Al-Tourah, L.
    Mithoowani, S.
    Lim, W.
    Ikesaka, Rick
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (04) : 630 - 637
12345